MedPath

ketamine role in depression treatment

Not Applicable
Conditions
Major Depression.
Registration Number
IRCT201104092266N2
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

IInclusion Criteria:
Known case of major depressive disorder without psychotic feature based on DSM IV-TR who Referred to ECT by a psychiatrist; age between 20-50 years; signing the consent form.

Exclusion Criteria

History of psychosis or being psychotic; substance abuse during recent 3 months; breast feeding mothers; having medical incapacitating disease such as: renal, hepatic, gastro intestinal, cardiovascular, endocrine, neurologic and hematologic disease based on history and clinical and Para clinical evaluations; history of seizure with unknown origin; uncontrolled hypo or hyper thyroidism ; simultaneous another psychiatric interventions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of major depressive symptoms. Timepoint: prior to each intervention session, one week, 1,2 and 3 month afer intervention. Method of measurement: structured interviewe based on Hamilton Depressive Rating Scale.
Secondary Outcome Measures
NameTimeMethod
Cognitive Side effects. Timepoint: Prior to intervention, one week and one month after intervention. Method of measurement: Adult Wechsler Memory Scal.
© Copyright 2025. All Rights Reserved by MedPath